GlassScriptPhysician profile
Douglas L Lefton
NPI 1205846045
$1,322.67
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $248 · 2021: $252.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $237.90 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $138.33 | 2021 | |
| Merck Sharp & Dohme LLC | $119.98 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $94.90 | 2019-2020 | |
| Allergan, INC. | $87.02 | 2019-2020 | |
| Glaxosmithkline, LLC. | $80.21 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $71.61 | 2019 | |
| Lilly USA, LLC | $68.40 | 2019-2021 | |
| Pfizer INC. | $66.05 | 2019-2020 | |
| Amarin Pharma, INC. | $56.54 | 2019 | |
| Sunovion Pharmaceuticals INC. | $55.18 | 2019-2021 | |
| Abbvie INC. | $46.86 | 2021 | |
| Novo Nordisk INC | $35.14 | 2019-2020 | |
| Abbott Laboratories | $34.97 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.68 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $23.43 | 2019 | |
| Qiagen, LLC | $18.47 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.95 | 2019 | |
| Radius Health, INC. | $16.87 | 2020 | |
| Sanofi-Aventis U.S. LLC | $14.64 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Lefton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.